Isoform switching and exon skipping induced by the DNA methylation inhibitor 5-Aza-2′-deoxycytidine
DNA methylation in gene promoters leads to gene silencing and is the therapeutic target of methylation inhibitors such as 5-Aza-2′-deoxycytidine (5-Aza-CdR). By analyzing the time series RNA-seq data (days 5, 9, 13, 17) obtained from human bladder cells exposed to 5-Aza-CdR with 0.1 uM concentration...
Main Authors: | Ding, Xiao-Lei, Yang, Xiaojing, Liang, Gangning, Wang, Kai |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835787/ |
Similar Items
-
Gene Reactivation by 5-Aza-2′-Deoxycytidine–Induced Demethylation Requires SRCAP–Mediated H2A.Z Insertion to Establish Nucleosome Depleted Regions
by: Yang, Xiaojing, et al.
Published: (2012) -
AID downregulation is a novel function of the DNMT inhibitor 5-aza-deoxycytidine
by: Tsai, Chiou-Tsun, et al.
Published: (2013) -
Exon skipping for DMD
by: Aartsma-Rus, Annemieke, et al.
Published: (2012) -
Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation
by: Momparler, Richard L, et al.
Published: (2014) -
GSTP1 DNA Methylation and Expression Status Is Indicative of 5-aza-2′-Deoxycytidine Efficacy in Human Prostate Cancer Cells
by: Chiam, Karen, et al.
Published: (2011)